261
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey

ORCID Icon, ORCID Icon, , ORCID Icon, , , , , & show all
Pages 384-389 | Received 16 Apr 2017, Accepted 18 Jan 2018, Published online: 08 Feb 2018

References

  • Adkins, J. E., Boyer, E. W., & McCurdy, C. R. (2011). Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry, 11(9), 1165–1175. doi:10.2174/156802611795371305
  • Administrative Committee on Substance Abuse Research Network. (2012). National Household Survey of Substance 2011. Bangkok, Thailand: Office of the Narcotics control Board.
  • Arndt, T., Claussen, U., Gussregen, B., Schrofel, S., Sturzer, B., Werle, A., & Wolf, G. (2011). Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer. Forensic Science International, 208(1–3), 47–52. doi:10.1016/j.forsciint.2010.10.025
  • Assanangkornchai, S., Muekthong, A., Sam-Angsri, N., & Pattanasattayawong, U. (2007). The use of Mitragynine speciosa (“krathom”), an addictive plant, in Thailand. Substance Use and Misuse, 42(14), 2145–2157. doi:10.1080/10826080701205869
  • Assanangkornchai, S., Pattanasattayawong, U., Samangsri, N., & Mukthong, A. (2007). Substance use among high-school students in Southern Thailand: Trends over 3 years (2002–2004). Drug and Alcohol Dependence, 86(2–3), 167–174. doi:10.1016/j.drugalcdep.2006.06.001
  • Boyer, E. W., Babu, K. M., Adkins, J. E., McCurdy, C. R., & Halpern, J. H. (2008). Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction, 103(6), 1048–1050. doi:10.1111/add.2008.103.issue-6
  • Boys, A., Marsden, J., & Strang, J. (2001). Understanding reasons for drug use amongst young people: A functional perspective. Health Education Research, 16(4), 457–469. doi:10.1093/her/16.4.457
  • Connor, J. P., Gullo, M. J., White, A., & Kelly, A. B. (2014). Polysubstance use: Diagnostic challenges, patterns of use and health. Current Opinion in Psychiatry, 27(4), 269–275. doi:10.1097/YCO.0000000000000069
  • Deering, D., Horn, J., & Frampton, C. M. (2012). Clients’ perceptions of opioid substitution treatment: An input to improving the quality of treatment. International Journal of Mental Health Nursing, 21(4), 330–339. doi:10.1111/j.1447-0349.2011.00795.x
  • Department of Health and Ageing Therapeutic Goods Administration. (2012). Poisons Standard. Anthony Gill, Australia.
  • European Monitoring Centre for Drugs and Drug Addiction. (2009). Polydrug Use: Pattern and Response. Spain: European Monitoring Centre for Drugs and Drug Addiction.
  • Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, N. H., Suhaimi, F. W., Vadivelu, R., … Muller, C. P. (2013). From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews, 37(2), 138–151. doi:10.1016/j.neubiorev.2012.11.012
  • Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the Internet. Substance Use and Misuse, 45(3), 330–340. doi:10.3109/10826080903443628
  • Jansen, K. L., & Prast, C. J. (1988). Ethnopharmacology of kratom and the Mitragyna alkaloids. Journal of Ethnopharmacology, 23(1), 115–119. doi:10.1016/0378-8741(88)90121-3
  • Jitpiromsri, S. (2005). Kratom abuse situation 2000-2004. In V. Poshyachinda & U. Perngparn (Eds.), A Situational Review of Substance Abuse in Thailand, 2000–2004 (pp. 13–15). Bangkok, Thailand: Administrative Committee on Substance Abuse Research Network.
  • Licata, S. C., & Renshaw, P. F. (2010). Neurochemistry of drug action. Annals Of The New York Academy Of Sciences, 1187, 148–171. doi: 10.1111/j.1749-6632.2009.05143.x
  • McIntyre, I. M., Trochta, A., Stolberg, S., & Campman, S. C. (2015). Mitragynine ‘Kratom’ related fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology, 39(2), 152–155. doi:10.1093/jat/bku137
  • Neerman, M. F., Frost, R. E., & Deking, J. (2013). A drug fatality involving kratom. Journal of Forensic Sciences, 58(Suppl 1), S278–279. doi:10.1111/1556-4029.12009
  • Oliveira, L. G., Alberghini, D. G., Santos, B., & Andrade, A. G. (2013). Polydrug use among college students in Brazil: A nationwide survey. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999), 35(3), 221–230. doi:10.1590/1516-4446-2012-0775
  • Prozialeck, W. C., Jivan, J. K., & Andurkar, S. V. (2012). Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association, 112(12), 792–799.
  • Quek, L. H., Chan, G. C., White, A., Connor, J. P., Baker, P. J., Saunders, J. B., & Kelly, A. B. (2013). Concurrent and simultaneous polydrug use: Latent class analysis of an Australian nationally representative sample of young adults. Front Public Health, 1, 61. doi:10.3389/fpubh.2013.00061
  • Singh, D., Muller, C. P., & Vicknasingam, B. K. (2014). Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence, 139, 132–137. doi:10.1016/j.drugalcdep.2014.03.017
  • Singh, D., Muller, C. P., Vicknasingam, B. K., & Mansor, S. M. (2015). Social functioning of kratom (Mitragyna speciosa) users in Malaysia. Journal of Psychoactive Drugs, 47(2), 125–131. doi:10.1080/02791072.2015.1012610
  • Suwanlert, S. (1975). A study of kratom eaters in Thailand. Bulletin on Narcotics, 27(3), 21–27.
  • Tanguay, P. (2011). Kratom in Thailand. Decriminalisation and community control? Legislative Reform of Drug Policies, 13, 1–16.
  • United Nations Office on Drugs and Crime. (2014). World Drug Report 2014. Geneva, Switzerland: United Nation Publication.
  • Vicknasingam, B., Narayanan, S., Beng, G. T., & Mansor, S. M. (2010). The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. The International Journal on Drug Policy, 21(4), 283–288. doi:10.1016/j.drugpo.2009.12.003

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.